ArticleTherapeutic advances in musculoskeletal disease2022

Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study).

Céleste J T van der Togt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.